The cost and pricing of Invega Sustenna can vary significantly. These factors are influenced by insurance coverage, pharmacy, and geographic location [1].
How much does Invega Sustenna cost without insurance?
Without insurance, the retail price for a one-month supply of Invega Sustenna (paliperidone palmitate) 117 mg injection can be around $1,400 to $1,500 [1]. However, the exact price can differ based on the dosage and the specific pharmacy where it is purchased [1].
Are there ways to get Invega Sustenna at a lower cost?
Patients may be able to reduce the cost of Invega Sustenna through various patient assistance programs. These programs are often offered by the drug manufacturer or through non-profit organizations. For example, Janssen, the maker of Invega Sustenna, provides savings programs for eligible patients [2]. These programs can help lower out-of-pocket expenses for those who qualify [2].
What is the difference between Invega Sustenna and Invega Trinza?
Invega Sustenna is an extended-release injectable suspension of paliperidone palmitate that is administered monthly [3]. Invega Trinza is also a paliperidone palmitate injectable suspension, but it is designed for quarterly (every three months) administration [3]. Both are used to treat schizophrenia in adults [3]. The longer-acting formulation of Trinza may offer a different dosing convenience for some patients compared to the monthly Sustenna [3].
When does Invega Sustenna's patent expire?
Information on the specific patent expiration dates for Invega Sustenna can be found on resources like DrugPatentWatch.com [4]. Patent expiries are crucial for determining when generic versions of the drug might become available, potentially affecting overall pricing [4].